Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Bempedoic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bempedoic acid (substance) |
Inferred relationship |
Some |
1 |
Bempedoic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bempedoic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing only bempedoic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bempedoic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing bempedoic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bempedoic acid (substance) |
Inferred relationship |
Some |
1 |
Bempedoic acid 180 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bempedoic acid (substance) |
Inferred relationship |
Some |
1 |
Bempedoic acid 180 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bempedoic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bempedoic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bempedoic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing bempedoic acid and ezetimibe (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bempedoic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing only bempedoic acid and ezetimibe (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bempedoic acid (substance) |
Inferred relationship |
Some |
2 |
Bempedoic acid- and ezetimibe-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bempedoic acid (substance) |
Inferred relationship |
Some |
2 |
Bempedoic acid and ezetimibe only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bempedoic acid (substance) |
Inferred relationship |
Some |
2 |